Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rifampin: a semisynthetic derivative of rifamycin--a prototype for the future.

× No keyword cloud information.

11 in total

1. Improved protein overexpression and purification strategies for structural studies of cyanobacterial metal-responsive transcription factor, SmtB from marine Synechococcus sp. PCC 7002.

Authors: Shelake Rahul Mahadev; Hidenori Hayashi; Takahisa Ikegami; Shunnosuke Abe; Eugene Hayato Morita
Journal: Protein J Date: 2013-12 Impact factor: 2.371

2. Management of streptococcal pharyngitis.

Authors: S Chaudhary
Journal: Indian J Pediatr Date: 1987 Sep-Oct Impact factor: 1.967

3. Interferon production by Shigella flexneri-infected fibroblasts depends upon intracellular bacterial metabolism.

Authors: C B Hess; D W Niesel; J Holmgren; G Jonson; G R Klimpel
Journal: Infect Immun Date: 1990-02 Impact factor: 3.441

4. Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis.

Authors: S H Siddiqi; A Aziz; Z Reggiardo; G Middlebrook
Journal: J Clin Pathol Date: 1981-08 Impact factor: 3.411

Review 5. Rifamycin antibiotics and the mechanisms of their failure.

Authors: Rebekah A Adams; Gabrielle Leon; Natalia M Miller; Saira P Reyes; Chantal H Thantrong; Alina M Thokkadam; Annabel S Lemma; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal: J Antibiot (Tokyo) Date: 2021-08-16 Impact factor: 2.649

6. Effect of rifampin on immunity to tuberculosis and on delayed hypersensitivity to purified protein derivative.

Authors: A S Youmans; G P Youmans; D Cahall
Journal: Infect Immun Date: 1976-01 Impact factor: 3.441

7. Evidence for stable messenger ribonucleic acid during sporulation and enterotoxin synthesis by Clostridium perfringens type A.

Authors: R G Labbe; C L Duncan
Journal: J Bacteriol Date: 1977-02 Impact factor: 3.490

Rifampin: a semisynthetic derivative of rifamycin--a prototype for the future.